Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Ex Vivo Large Scale Generation of Human Platelets from Cord Blood CD34+ Cells.

Takuya Matsunaga, MD, PhD, Ikuta Tanaka, MD, PhD, Masayoshi Kobune, MD, PhD, Yutaka Kawano, MD, PhD, Maki Tanaka, MD, PhD, Takehide Akiyama, MD, Kageaki Kuribayashi, MD, PhD, Takafumi Ninomiya, PhD, Hirofumi Hamada, MD, PhD, Yoshiro Niitsu, MD, PhD

Blood (2005) 106 (11): 1892.

https://doi.org/10.1182/blood.V106.11.1892.1892

Published: 2005

Journal Articles

Combination Therapy of Humanized Chimeric-Anti-Human VLA4 Monoclonal Antibodies and Anti-Cancer Drugs for AML.

Takuya Matsunaga, MD, Kazunori Kato, PhD, Maki Tanaka, MD, Yukari Masuta, PhD, Kageaki Kuribayashi, MD, Naofumi Takemoto, MD, Ikuta Tanaka, MD, Akihito Fujimi, MD, Takehide Akiyama, MD, Hirofumi Hamada, MD, Yoshiro Niitsu, MD

Blood (2004) 104 (11): 4518.

https://doi.org/10.1182/blood.V104.11.4518.4518

Published: 2004

Journal Articles

Ex Vivo Production of Transfusable Red Blood Cells at Large Scale from Cord Blood CD34+ Cells Using a Coculture System with Human Telomerase Catalytic Subunit (hTERT)-Transfected Human Stromal Cells at Early Phase and with Acitivated Macrophage from Cord Blood CD34+ Cells at Late Phase.

Akihito Fujimi, MD, Takuya Matsunaga, MD, Masayoshi Kobune, MD, Yutaka Kawano, MD, Ikuta Tanaka, MD, Naofumi Takemoto, MD, Takehide Akiyama, MD, Hirofumi Hamada, MD, Yoshiro Niitsu, MD

Blood (2004) 104 (11): 2701.

https://doi.org/10.1182/blood.V104.11.2701.2701

Published: 2004

Journal Articles

Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603

Yue Lu, Sumio Sakamaki, Hiroyuki Kuroda, Toshiro Kusakabe, Yuichi Konuma, Takehide Akiyama, Akihito Fujimi, Naofumi Takemoto, Kyokusen Nishiie, Takuya Matsunaga, Yasuo Hirayama, Junji Kato, Shinichiro Kon, Katsuhisa Kogawa, Yoshiro Niitsu

Blood (2001) 97 (4): 1123–1130.

https://doi.org/10.1182/blood.V97.4.1123

Published: 2001

Journal Articles

Transforming Growth Factor-β1 (TGF-β1) Induces Thrombopoietin From Bone Marrow Stromal Cells, Which Stimulates the Expression of TGF-β Receptor on Megakaryocytes and, in Turn, Renders Them Susceptible to Suppression by TGF-β Itself With High Specificity

Sumio Sakamaki, Yasuo Hirayama, Takuya Matsunaga, Hiroyuki Kuroda, Toshiro Kusakabe, Takehide Akiyama, Yuichi Konuma, Katsunori Sasaki, Naoki Tsuji, Tetsuro Okamoto, Masayoshi Kobune, Katsuhisa Kogawa, Junji Kato, Rishu Takimoto, Ryuzo Koyama, Yoshiro Niitsu

Blood (1999) 94 (6): 1961–1970.

https://doi.org/10.1182/blood.V94.6.1961

Published: 1999

NARROW

Ex Vivo Large Scale Generation of Human Platelets from Cord Blood CD34+ Cells.

Combination Therapy of Humanized Chimeric-Anti-Human VLA4 Monoclonal Antibodies and Anti-Cancer Drugs for AML.

Ex Vivo Production of Transfusable Red Blood Cells at Large Scale from Cord Blood CD34+ Cells Using a Coculture System with Human Telomerase Catalytic Subunit (hTERT)-Transfected Human Stromal Cells at Early Phase and with Acitivated Macrophage from Cord Blood CD34+ Cells at Late Phase.

Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603

Transforming Growth Factor-β1 (TGF-β1) Induces Thrombopoietin From Bone Marrow Stromal Cells, Which Stimulates the Expression of TGF-β Receptor on Megakaryocytes and, in Turn, Renders Them Susceptible to Suppression by TGF-β Itself With High Specificity

Email alerts

ASH Publications

American Society of Hematology

Ex Vivo Large Scale Generation of Human Platelets from Cord Blood CD34+ Cells.

Combination Therapy of Humanized Chimeric-Anti-Human VLA4 Monoclonal Antibodies and Anti-Cancer Drugs for AML.

Ex Vivo Production of Transfusable Red Blood Cells at Large Scale from Cord Blood CD34+ Cells Using a Coculture System with Human Telomerase Catalytic Subunit (hTERT)-Transfected Human Stromal Cells at Early Phase and with Acitivated Macrophage from Cord Blood CD34+ Cells at Late Phase.

Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603

Transforming Growth Factor-β1 (TGF-β1) Induces Thrombopoietin From Bone Marrow Stromal Cells, Which Stimulates the Expression of TGF-β Receptor on Megakaryocytes and, in Turn, Renders Them Susceptible to Suppression by TGF-β Itself With High Specificity

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only